Posted by Michael Wonder on 10 Aug 2024
Two new treatment options for incurable blood cancer assessed
9 August 2024 - We’ve recommended 2 new treatments for multiple myeloma, an incurable blood cancer that affects bone marrow, in draft guidance issued for public consultation.
In total we’ve now made 14 positive recommendations for multiple myeloma treatments in the past 5 years.
Positive recommendations for elranatamab are open for consultation until 9 August 2024 and teclistamab until 13 August 2024.
